Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9  by Arai, Shigeki et al.
FEBS Letters 581 (2007) 5649–5657Novel homeodomain-interacting protein kinase family member,
HIPK4, phosphorylates human p53 at serine 9
Shigeki Araia, Akio Matsushitaa, Kun Dua, Ken Yagib, Yasushi Okazakib, Riki Kurokawaa,*
a Division of Gene Structure and Function, Research Center for Genomic Medicine, Saitama Medical University, Japan
b Division of Functional Genomics and Systems Medicine, Research Center for Genomic Medicine, Saitama Medical University, Japan
Received 13 September 2007; revised 2 November 2007; accepted 4 November 2007
Available online 20 November 2007
Edited by Varda RotterAbstract We describe here the cloning and characterization of
a novel mouse homeodomain-interacting protein kinase (HIPK)-
like gene, Hipk4. Hipk4 is expressed in lung and in white adipose
tissue and encodes a 616 amino acid protein that includes a ser-
ine/threonine kinase domain. We demonstrate that HIPK4 could
phosphorylate human p53 protein at serine 9, both in vitro and
in vivo. Among known p53-responsive promoters, activity of
the human survivin promoter, which is repressed by p53, was de-
creased by HIPK4 in p53 functional A549 cells. Human BCL2-
associated X protein-promoter activity was not aﬀected. These
ﬁndings suggest that phosphorylation of p53 at serine 9 is impor-
tant for p53 mediated transcriptional repression.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Apoptosis1. Introduction
The mammalian genome encodes 500 protein kinase-like
domain containing proteins that putatively phosphorylate ser-
ine, threonine or tyrosine residues of target proteins [1]. Pro-
teins that become phosphorylated may alter characteristics,
including enzymatic activity, half-life, localization, and partner
binding [2]. Mammalian homeodomain-interacting protein
kinases (HIPKs), HIPK1, 2 and 3, are members of the nuclear
serine/threonine kinase family [3,4]. HIPKs are localized in
nuclear speckles and phosphorylate several proteins, including
homeodomain transcription factor NKx-1.2, androgen recep-
tor and tumor suppressor p53 [3–5]. p53 is phosphorylated at
several serine and threonine residues including 6, 9, 15, 20,
33, 37, 46, and 392 in response to various signals, such as geno-
toxic stress (e.g., ultraviolet (UV), ionizing radiation and
anti-cancer agents) and non-genotoxic stress (e.g., hypoxia,
senescence, and osmotic shock) [6–8]. Site-speciﬁc phosphory-
lation of p53 regulates its activity. For example, HIPK2 phos-Abbreviations: HIPK, homeodomain-interacting protein kinase; UV,
ultraviolet; MBP, myelin basic protein; GFP, green ﬂuorescent
protein; NCBI, national center for biotechnology information; GAP-
DH, glyceraldehyde-3-phosphate dehydrogenase; MDM2, mouse
double minute 2 homolog; BAX, BCL2-associated X protein
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doi:10.1016/j.febslet.2007.11.022phorylates human p53 at Ser46 and co-repressor CtBP at
Ser422, which induces apoptotic cell death [5,9]. DNA damage
induces phosphorylation of p53 at Ser15 and Ser37 and inhibits
interaction of p53 and its negative regulator, oncoprotein
mouse double minute 2 homolog (MDM2) [10]. Human p53
is rapidly phosphorylated at Ser9 after exposure to c-rays and
to UV light. Several kinases, such as casein kinase 1d (CK1d),
CK1e, and DNA-PK have the ability to phosphorylate p53 at
Ser9, in addition to several other serine residues, but the
detailed role of phospho-p53 (Ser9) is not clear [11]. Recently,
Cordenonsi et al. reported that human p53, phosphorylated
at Ser9, and injected into Xenopus embryos, serves as an activa-
tor of mesoderm marker genes and that phospho-p53 (Ser9)
promotes TGF-b cytostasis in human cells [12]. In the latter
case, phospho-p53 (Ser9) induces the formation of a complex
with Smad2 and activates transcription of several TGF-b target
genes, such as p21Waf1 and p15INK4b.
We show here that HIPK4, the product of a previously
uncharacterized kinase-like gene [13], has direct kinase activity
on human p53 at serine 9 in vitro and in vivo. We observed
that over-expression of Hipk4 in A549 cells decreased the pro-
moter activity of human survivin, which is an anti-apoptotic
gene and which is directly repressed by p53 at the transcrip-
tional level [14,15]. Interestingly, the human BCL2-associated
X protein (BAX) promoter, which is a pro-apoptotic, and
direct-target gene of p53 [16,17], was not aﬀected by HIPK4.
These results will further the understanding of cell prolifera-
tion and of diﬀerentiation pathways that are under the control
of the p53 network, especially in circumstances where p53
phosphorylation at serine 9 is tightly regulated.2. Materials and methods
2.1. Materials
Cultured cell lines were obtained from Cell Resource Center for Bio-
medical Research, Tohoku University. Oligonucleotides, for PCR
primers, were synthesized by Hokkaido System Science (Hokkaido,
Japan). Pwo SuperYield DNA Polymerase (Roche, Mannheim,
Germany) was used for PCR experiments. Reagents for RNA isolation
and for cDNA synthesis were purchased from Invitrogen (Carlsbad,
CA). Antibodies were purchased from Cell Signaling Technology
(Beverly, MA). Myelin basic protein (MBP) and puriﬁed histone pro-
teins were obtained from Sigma–Aldrich (St. Louis, MO) and from
Roche, respectively.
2.2. Cloning, sequencing and PCR
The open reading frame of Hipk4 was predicted from mouse geno-
mic DNA clone (NC_000073.5). Primer pairs, HIPK4-fw 5 0-atggccac-
catccagtcaggacactg-30 and HIPK4-rv 5 0-tcagtggtgccctccaacatgctg-30,blished by Elsevier B.V. All rights reserved.
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used for cloning of the Hipk4 cDNA. PCR products from NIH/3T3
cDNA and mouse lung cDNA were sequenced using the ABI-377 se-
quencer using the BigDye Terminator 3.1 Kit (Applied Biosystems,
Foster City, CA). For RT-PCR experiments, we used the following oli-
gonucleotide pairs. For glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) ampliﬁcation, primer sets were: fw-primer 5 0-cat-
caccatcttccaggagcg-3 0 and rv-primer 5 0-caccaccttcttgatgtcatc-3 0. For
human and mouse HIPK4 ampliﬁcation, primer sets were: fw-primer
5 0-accagattgagacagtgaatggtgg-3 0 and rv-primer 5 0-caytctccaggacagc-
tgctggg-3 0 (y indicates c and t mixture).
2.3. Western blotting
Western blotting was performed following standard protocols using
nitrocellulose membrane (Bio-Rad Laboratories, Richmond, CA).
Protein samples of cultured cells were extracted in WCE buﬀer
[25 mM HEPES (pH 7.9), 150 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 0.05% Triton-X100, 10% glycerol] by sonication, followed by
centrifugation at 14000 · g for 10 min at 4 C. Polyclonal anti-HIPK4
antibody was raised in rabbit by injection of puriﬁed 6 · His-HIPK4
(162–553 aa) antigen. Subcutaneous injection was performed four
times using Complete Freund’s Adjuvant (DIFCO LABORATORIES,
Detroit, MI) at day 0, and using Incomplete Freund’s Adjuvant (DIF-
CO LABORATORIES) at days 10, 20, and 30. Serum was isolated at
day 40. This anti-serum was used, at a dilution of 1:1000, in PBS
[137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4]
containing 0.05% Tween 20 and 2% skimmed milk, overnight at
4 C. HRP-linked anti-rabbit IgG (Cell Signaling Technology) was
incubated, at a dilution of 1:4000, in PBS containing 0.05% Tween
20 and 2% skimmed milk for 1 h at room temperature. For protein
detection, we used Supersignal West-Pico System (Pierce, Rockford,
IL) and Hyperﬁlm MP (GE Healthcare, Piscataway, NJ). In vitro
translated HIPK4 protein was prepared using TNT quick-coupled
transcription/translation systems (Promega, Madison, WI).
2.4. Cell fractionation
Sub-conﬂuent cells, grown on a 15-cm plate, were dounced in hypo-
tonic buﬀer (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2,
0.5 mM DTT, 0.2 mM PMSF) until at least 95% of the cells were dis-
rupted. The cytoplasmic fraction was obtained as supernatant after
centrifugation at 3300 · g for 15 min. The pellet was solubilized with
SDS sample buﬀer, yielding the nuclear fraction. Both cytoplasmic
and nuclear fractions were analyzed by Western blotting.
2.5. Protein expression and puriﬁcation
Full-length mouse Hipk4 cDNA, containing the FLAG epitope se-
quence at the amino-terminal, was cloned into pFastBac1 vector
(Invitrogen). Protein production was performed according to the
Bac-to-Bac system (Invitrogen). Protein was extracted from HIPK4
expressing Sf9 cells in WCE buﬀer by sonication, and by centrifugation
at 14000 · g for 10 min at 4 C. The soluble fraction was stored at
80 C until use.
2.6. In vitro kinase assay
For kinase assays, 100 ll of HIPK4 lysate was mixed with 15 ll of
anti-FLAG M2 agarose conjugated antibody (Sigma–Aldrich) for
30 min at 4 C. The beads were then washed 4 times with kinase reac-
tion buﬀer [10 mM Tris–HCl (pH 7.5), 150 mM NaCl, 10 mM MgCl2,
0.5 mM DTT, 0.001% Tween 20]. Antibody bound proteins were
eluted in kinase buﬀer, containing a ﬁnal concentration of 0.4 mg/ml
FLAG peptide (Sigma–Aldrich), for 10 min on ice, and separated by
centrifugation at 1000 · g for 1 min at 4 C. Enzymatic reactions were
composed as follows: 50 ng of HIPK4, 1 lg of substrate protein,
10 lM ATP, 0.5 Ci/mmol [c-32P]ATP (GE Healthcare), 10 mM Tris–
HCl (pH 7.5), 150 mM NaCl, 10 mM MgCl2, 0.5 mM DTT, 0.001%
Tween 20 in a total volume of 40 ll. Incubation was performed at
30 C for 20 min. Reactions were terminated by the addition of
4 · Sample buﬀer: 200 mM Tris–HCl (pH 6.8), 86 mg/ml SDS,
0.2 ml/ml 2-mercaptethanol, 0.28 ml/ml glycerol, 0.1 mg/ml bromophe-
nol blue. These samples were separated by 10% SDS–PAGE (for p53
protein) or 16% SDS–PAGE (for MBP and histones) and were de-
tected by autoradiography. Polypeptides for p53 phosphorylation as-
says were expressed in Escherichia coli, which were transformed with
pASK-IBA5-human p53 or with pGEX6p-1-mouse p53 (1–40 aa).Aﬃnity-puriﬁcation of these samples was performed using Strep-Tac-
tin Sepharose (IBA, Gottingen, Germany) or Glutathione-Agarose
(Sigma–Aldrich). Mutant protein of human p53 Ser9Ala (p53-S9A)
was constructed using KOD-Plus-mutagenesis Kit (TOYOBO, Osaka,
Japan).
2.7. Cellular localization analysis
A Green ﬂuorescent protein (GFP)-HIPK4 expression vector was
engineered by the insertion of Hipk4 into vector pAcGFP1-C3 (Clon-
tech, Palo Alto, CA). Transient transfection was performed using Fu-
Gene HD reagent (Roche), following the manufacturers instructions.
COS-1 cells, into which the GFP-HIPK4 expression plasmid had been
introduced, were cultured for 48 h in DMEM medium (Invitrogen)
containing 10% fetal bovine serum (invitrogen), and were then ﬁxed
with 4% formaldehyde in PBS for 30 min on ice. For the staining of
DNA, Hoechest 33258 (Nacalai Tesque, Kyoto, Japan) was added at
a ﬁnal concentration of 1 mM. The IX71 system (Olympus, Tokyo,
Japan) was used for ﬂuorescent microscopy analysis.
2.8. Transient transfection and reporter assay
We performed transient transfection assays using the Lipofectamine
2000 reagent (Invitrogen) following the supplier’s protocol. Brieﬂy,
3 · 105 A549 cells were seeded on a 12-well plate 24 h before transfec-
tion. To each well were added 1.6 lg of DNA and 4 ll of Lipofect-
amine 2000. Six hundred nanograms of expression vector; either
pcDNA3.1 mock vector, pcDNA3.1-FLAG-HIPK4 or pcDNA3.1-
FLAG-HIPK4-K40S, was added with 400 ng of pRL-TK vector (Pro-
mega) (as an internal control) and 600 ng of luciferase expression vec-
tor (2 · p53-RE-tk-luc, tk-luc, human BAX-luc or human survivin-luc)
(to assess p53 activity). Human BAX- and survivin-luc vectors were
ampliﬁed from human genomic DNA using the following PCR primer
sets. For human BAX promoter (174/+109 bp) ampliﬁcation, primer
sets were: fw-primer 5 0-gacgcgtagctcatgcctgtaatcccagc-3 0 and rv-primer
5 0-gagatctaatgccttcatttatccaggc-3 0. For human survivin promoter
(148/+105 bp) ampliﬁcation, primer sets were: fw-primer 5 0-gac-
gcgttctttgaaagcagtcgagg-30 and rv-primer 5 0-tagatctgccaacgggtcccgcg-
attc-3 0. The ampliﬁed DNA fragments were inserted into MluI and
BglII sites of pGL3-Basic vector (Promega). The activities of Fireﬂy
luciferase and Renilla luciferase were measured by the Dual Luciferase
reporter assay system (Promega). Each data point was assayed in trip-
licate. Experiments were repeated at least three times.
2.9. Statistical analysis
Data were compared using the paired Student’s t-test. P-values
<0.05 were considered signiﬁcant.3. Results and discussion
3.1. Cloning of Hipk4 cDNA
Numerous kinds of extra- and intra-cellular stimuli activate
protein kinase pathways, and coordinate the phosphorylation
status of transcription factors and of nucleosomal proteins.
To discover a novel kinase that aﬀects the gene-regulation net-
work, we searched for candidate proteins in the National Cen-
ter for Biotechnology Information (NCBI) database with the
search term Cd00180 (a serine/threonine kinase domain). In
the Homologene Database (http://www.ncbi.nlm.nih.gov/
HomoloGene), we found an uncharacterized kinase-like pro-
tein, deposited as HIPK4. We focused on this protein, because
HIPK family members are localized in the nucleus and regu-
late the transcriptional activities of several transcription fac-
tors. Human HIPK4 was originally cloned by the NIH full-
length cDNA project, but its expression level in tissues and
its kinase activity were not characterized [13]. Because the
complete coding sequence of the mouse orthologue, Hipk4,
had not been determined, we tried to clone the full-length
Hipk4 cDNA using RT-PCR. We successfully ampliﬁed full
S. Arai et al. / FEBS Letters 581 (2007) 5649–5657 5651length Hipk4 from mouse lung and from NIH/3T3 cells. Hipk4
encodes a 616 amino acid protein, including a serine/threonine
kinase domain in its amino-terminal region (supplementary
Fig. 1A). Hipk4 also has a predicted PEST sequence in the car-
boxy-terminal region, like other HIPK family members (sup-
plementary Fig. 1B). The PEST sequence, which is a Pro/
Glu/Ser/Thr-rich region, ﬂanked by two Lys/Arg residues, is
related to protein stability [18]. Fig. 1A illustrates the conser-
vation between kinase domains of HIPK4 and of known
mouse HIPK family members. Over 85% of residues within
the kinase domain were identical between HIPK1, 2 and 3,
whereas the similarity of HIPK4 to HIPK1-3 was slightly low-
er. About 50% of residues in the HIPK4-kinase domain were
identical to those of HIPK1-3. Compared with known pro-
teins, HIPK4 shows the highest similarity to HIPK1, however,
it is possible that HIPK4 is a member of an independent
protein kinase family because of its moderate homology to
HIPK1-3. However, the important amino acids for kinase
function were conserved in all HIPK members.Fig. 1. Mouse HIPK4 is a novel homeodomain-interacting protein kinase like
from mouse HIPK family members. Alignment was calculated by the MAF
HIPK1 (NP_034562.1), HIPK2 (NP_034563.1) and HIPK3 (NP_034564.1)
identical, very similar or similar, respectively. A kinase-dead mutant protein
(boxed). Nucleotide sequence of mouse Hipk4 is deposited in GenBank, Acce
mRNA. Results of RT-PCR experiments for HIPK4 and for GAPDH of mou
ampliﬁcation cycles required to detect HIPK4 and GAPDH were 32 cycles a3.2. Tissue and cell line distribution of HIPK4 mRNA and
protein
We performed RT-PCR to characterize the distribution of
human and mouse HIPK4 mRNAs. We designed the primer
pairs to be on diﬀerent exons to distinguish the size of products
from cDNA and genomic DNA. Hipk4 was expressed moder-
ately in mouse lung and white adipose tissue, and was weakly
expressed in brain and liver (Fig. 1B). Hipk4 expression was
detected in NIH/3T3 and C2C12 cells, which are derived from
mouse embryo and from myoblasts, respectively. Human
HIPK4 mRNA was detected in A549 (lung cancer), Jurkat
(T cell leukemia), PC-3 (prostate cancer) and THP-1 (mono-
cytic leukemia) cells. To conﬁrm the expression of HIPK4
protein, we performed Western blot analysis using rabbit
polyclonal anti-HIPK4 antibody. Endogenous HIPK4 of
NIH/3T3 cells was detected, corresponding to the size (approx-
imate molecular mass of 80 kDa) of in vitro translated HIPK4
(Fig. 2B). This indicated that the Hipk4 cDNA contained the
full-length open reading frame.protein. (A) Amino acid alignment of serine/threonine kinase domains
FT program. GenBank Accession Numbers, used for alignment, were
. The symbols (*), (:) and (.) indicate amino acid residues that were
was engineered by introducing the point-mutation lysine 40 to serine
ssion Number AB354583. (B) Tissue and cell line distribution of Hipk4
se tissues and of mouse and human cell lines are shown. The number of
nd 20 cycles, respectively.
Fig. 2. HIPK4 is mainly localized in the cytoplasm. (A) GFP-HIPK4 expression vectors were introduced into COS-1 cells (left panel) and into A549
cells (right panel) by FuGENE HD reagent. After culture for 48 h, cells were ﬁxed with 4% formaldehyde, and analyzed by ﬂuorescent microscopy.
One mM (ﬁnal) of Hoechst 33258 was used to stain DNA. (B) Detection of endogenous HIPK4 in NIH/3T3 cells. Protein fractions of cytoplasmic
(C) and of nuclear (N) extract of NIH/3T3 cells, whole cell extract of mHIPK4-transfected COS-1 cells, and in vitro translated (IVT) mHIPK4 were
separated by 10% SDS–PAGE, and transferred onto nitrocellulose membrane, followed by immunoblot analysis using rabbit polyclonal anti-HIPK4
antibody. For the IVT reaction, pcDNA3.1() (as negative control) and pcDNA3.1()-mHIPK4 were used.
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HIPKs are localized in the nucleus, especially in nuclear
speckles [3,4,19]. Nuclear speckles are complexes containing
protein factors for transcription, splicing factors and factors
for the nuclear export of mRNA. We examined the cellular
localization of HIPK4, by the transient transfection of a
GFP-HIPK4 fusion protein into A549 and COS-1 cells.
GFP-HIPK4 signal was observed throughout the cytoplasm
and weakly in nucleus (Fig. 2A). This result is reﬂected in that
HIPK4 does not have a typical nuclear localization signal
(NLS). As expected, from the localization of GFP-HIPK4,
endogenous HIPK4 in NIH/3T3 cells was detected in the cyto-
plasmic fraction by Western blot analysis (Fig. 2B). Recently,
Taira et al. reported that dual-speciﬁcity tyrosine-phosphory-
lation-regulated kinase 2 (DYRK2) localizes to the nucleus
in response to genotoxic stress and phosphorylates human
p53 at serine 46 [19]. This raises the possibility that HIPK4
localizes to nucleus in response to certain stimuli.3.4. Catalytic activity of HIPK4
Members of the HIPK family can phosphorylate several
transcription factors and are capable of auto-phosphorylation
[4,20]. We performed kinase assays using recombinant mouse
HIPK4 expressed in Sf9 insect cells (HIPK4 produced inE. coli had very weak auto-phosphorylation activity (data
not shown) and was, therefore, not used). We made two kinds
of HIPK4 proteins containing the FLAG-sequence; one was
wild-type (wt) and the other carried a point mutation resulting
in the substitution of lysine 40 to serine (K40S). These two pro-
teins were produced at similar levels, conﬁrmed by Coomassie-
staining and by Western blot analysis (Fig. 3A). Then, these
proteins were assayed for kinase activity using MBP, histone
H1, H2A, H2B, H3 and H4 as substrates [21,22]. We detected
signiﬁcant phosphorylation activity for MBP and for histone
H3, but not for histone H1, H2A, H2B or H4 (Fig. 3B). As
with other HIPK family members, auto-phosphorylation
activity was observed for HIPK4-wt (Fig. 3B). HIPK4-K40S
mutant protein did not exhibit kinase activity, either to itself
or to any of the substrate proteins (Fig. 3B). These results sug-
gest that HIPK4 has an intrinsic kinase activity, and that there
was no contamination with any other kinase. Post-transla-
tional modiﬁcation of histone H3 inﬂuences cellular responses,
such as gene regulation and cell division. Several kinases
including MSK1/2, Aurora kinase B, DLK/ZIP and HASPIN
have phosphorylation activity to Histone H3 and regulate
chromosome condensation, metaphase chromosome alignment
and cytokinesis [23–27]. Although the amount of HIPK4 in the
nucleus was low, it would be interesting to investigate the pos-
sibility that H3 is a target of HIPK4 in vivo.
Fig. 3. HIPK4 possesses direct kinase activity towards MBP and Histone H3 in vitro. (A) Puriﬁcation of recombinant HIPK4 protein and of the
mutant, HIPK4-K40S. The aﬃnity-puriﬁed samples of recombinant HIPK4 proteins, produced in insect cells, were separated by 10% of SDS–PAGE
and stained by Coomassie Brilliant Blue (left panel). Immunoblot analysis using anti-FLAG M2 antibody is shown in the right panel. (B)
Phosphorylation of MBP and of histone H3 by HIPK4. The kinase property of HIPK4 was characterized by an in vitro kinase assay using substrate
proteins, as indicated. [32P]-labeled proteins were detected by autoradiography (left panel). The kinase properties of wild-type (wt) HIPK4 and of
point mutant (K40S) HIPK4 were characterized by an in vitro kinase assay using MBP and histone H3 (right panel).
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HIPK2 phosphorylates human p53 at serine 46 and induces
apoptotic responsive genes [5]. We, therefore, investigated the
possibility of p53 phosphorylation mediated by HIPK4. We
detected substantial phosphorylation of human p53 by HIPK4
in an in vitro kinase assay (Fig. 4A). There are a number of re-
ported phosphorylation sites in human p53, such as at serine 6,9, 15, 20, 33, 37, 46, 392 and threonine 18 [5–8]. We, therefore,
further investigated the residues of human p53 targeted by
HIPK4 by using anti-p53 antibodies that recognize site-speciﬁc
phosphorylation. We detected phosphorylation of p53 at ser-
ine 9, but not at 6, 15, 20, 37, or 46 (Fig. 4B and supplementary
Fig. 2A). We performed further in vitro kinase assays using the
mutant protein, human p53 Ser9Ala, to conﬁrm the target site
Fig. 4. HIPK4 phosphorylates human p53 at serine 9. (A) Phosphorylation of human p53 by HIPK4 in vitro. Aﬃnity-puriﬁed, full-length human
p53 was incubated with or without HIPK4-wt or HIPK4-K40S, for 20 min at 30 C. [32P]-labeled proteins were detected by autoradiography. Right
panel shows the loading control of left panel. (B) HIPK4 phosphorylates human p53 at serine 9. Aﬃnity-puriﬁed full-length human p53 protein was
phosphorylated in vitro with or without HIPK4, and 10% SDS–PAGE was performed. After these samples were transferred onto membrane,
immunoblot analysis was performed using rabbit polyclonal anti-phospho-human p53 (Ser9) antibody. (C) Aﬃnity-puriﬁed full-length wild-type (wt)
human p53 and its point mutant serine 9 to alanine (S9A) were incubated, with or without HIPK4-wt, for 20 min at 30 C. [32P]-labeled proteins were
detected by autoradiography. Right panel shows the loading control of left panel. (D) Alignment of the N-terminal sequences of human, mouse and
rat p53 proteins. These sequences were derived from GenBank Accession Numbers: NP_000537.2 (human), NP_035770.1 (mouse) and NP_112251.1
(rat). (E) Phosphorylation of mouse p53 by HIPK4. Aﬃnity-puriﬁed GST-mouse p53 (1–40 aa) and full-length mouse p53 protein was incubated
with or without HIPK4 for 20 min at 30 C. [32P]-labeled-proteins were detected by autoradiography.
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body (Fig. 4C and supplementary Fig. 2B). The amount of
phospho-human p53 (Ser9) was dramatically decreased by
the Ser9Ala mutation, therefore, we concluded that HIPK4
preferentially phosphorylates human p53 at serine 9. The se-quence of p53 (Ser9) is conserved in mouse, rat and human,
but the surrounding sequence is diﬀerent (Fig. 4D). This ﬁnd-
ing indicates that this serine residue is important in transcrip-
tional control mediated by HIPK4. We, therefore, performed
in vitro kinase assays using full-length mouse p53 and
Fig. 5. Over-expression of HIPK4 decreases human survivin gene promoter activity. (A) Eﬀect on p53-responsive promoter activity by HIPK4.
Expression vector (HIPK4-wt or HIPK4-K40S) and reporter vector, as indicated, were transiently introduced into human, lung cancer derived, A549
cells. Fireﬂy luciferase activities, after normalization by Renilla luciferase, are shown. Each experiment was repeated at least three times and error
bars represent S.D. values of triplicated samples. (B) Phosphorylation status of human p53 in HIPK4 over-expressing cells. Protein samples of COS-1
cells were prepared 24 h after the transfection of a p53 expression vector, with or without, co-transfection of a HIPK4 expression vector. These
samples were separated by 10% SDS–PAGE and transferred onto PVDF membrane. Phosphorylation levels of p53 were analyzed using anti-
phospho-p53 (Ser9) antibody. Protein levels of p53, HIPK4 and b-actin were assayed using respective antibodies.
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tides were phosphorylated by HIPK4, hence, HIPK4 might
have the ability to phosphorylate mouse p53 (Ser12) which
corresponds to human p53 (Ser9). Casein kinase 1d (CK1d)
can phosphorylate human p53 at Ser6 and Ser9 in vitro, but
prior phosphorylation of Ser6 is necessary for Ser9 phosphor-
ylation [6]. As phosphorylation of human p53 (Ser9) by
HIPK4 occurred in the absence of phospho-p53 (Ser6), HIPK4
could be the ﬁrst p53 (Ser9) principal kinase to be identiﬁed,
and could be important for the rapid phosphorylation of p53
(Ser9).3.6. HIPK4 represses survivin gene promoter activity
Properties of p53, such as localization and stability, are
aﬀected by phosphorylation. Although phospho-p53 (Ser9) has
been observed in several types of cells in response to UV,
H2O2, adriamycin and TGF-b [6,8,12,28], there is little informa-
tion about the function of Ser9 phosphorylation. We investi-
gated the eﬀect of HIPK4 over-expression on a synthetic p53
responsive element containing the promoter (2 · RE-tk-luc)
and on two kinds of human p53-dependent gene promoter
(BAX-luc and survivin-luc), using a luciferase assay in A549 cells,
which express functional p53. We selected the human BAX
5656 S. Arai et al. / FEBS Letters 581 (2007) 5649–5657promoter as a pro-apoptotic, p53-dependent inducible promoter
[14,15]. The human survivin promoter was investigated as an
anti-apoptotic, p53-dependent repressive promoter [16,17].
A549 cells, transfectedwithHIPK4, showed a remarkable reduc-
tion of luciferase activity in 2 · RE-tk-luc and in human survivin-
luc transfected cells, compared with control cells (Fig. 5A). The
kinase mutant, HIPK4-K40S, did not have such an eﬀect on
2 · RE-tk-luc transfected cells. HIPK4-K40S slightly increased
the human survivin promoter activity. Thus, these repression ef-
fects on 2 · RE-tk-luc and human survivin promoter were
HIPK4 kinase activity dependent. Interestingly, HIPK4 did
not aﬀect the activity of the BAX promoter. Although further
experiments using various gene promoters are necessary, we pre-
sume that HIPK4 primarily aﬀects the activity of p53 repressive
promoters. The phosphorylation status of endogenous p53
could not be characterized because the sensitivity of the anti-
phospho-p53 (Ser9) antibody was too low. Therefore, we intro-
duced human p53 and mouse HIPK4 expression vectors into
COS-1 cells, and analyzed the phosphorylation status of exoge-
nous human p53. We detected the phosphorylation of human
p53 at serine 9mediated byHIPK4 in vivo (Fig. 5B). Thus, phos-
pho-p53 (Ser9), produced by HIPK4, increases the repression
activity of p53 at p53 repressive promoters.
There are number of reports that document the site-speciﬁc
phosphorylation of p53, such as at serine 15, 20, and 46, to be
involved in the activation of transcription [5,8,10]. Notably,
phospho-p53 (Ser46) has been reported to selectively induce
apoptotic genes. There is little evidence that p53-phosphoryla-
tion correlates with gene repression. Ando et al. reported that
polo-like kinase 1 (PLK1) inhibited p53 transcriptonal activity
[29]. Recently, Chen et al. reported that this inhibition was due
to the activation of cdc25c phosphatase by PLK1, not due to
direct phosphorylation of p53 [30]. There are several possibilities,
including a direct or an indirect eﬀect of HIPK4, with regard to
the inhibition of activity of selective gene promoters by p53.
Several factors, such as DNMT1 and Sin3, had been reported
as co-repressors of p53 in the human survivin promoter system
[14,31]. Therefore, we speculate that phospho-p53 (Ser9)
enhances the binding aﬃnity of these factor(s). Further analysis
is necessary to elucidate the precisemechanismof p53-repression.
We have described here that HIPK4, which is expressed in
lung and white adipose tissue, can directly phosphorylate
human p53 (Ser9) both in vitro and in vivo. We also demon-
strated the possibility that the kinase activity of HIPK4 is
important for the repressive function of p53. Additional stud-
ies of HIPK4 would provide further understanding of the cel-
lular events that are regulated by p53, such as apoptosis, DNA
repair and cell-cycle progression.Acknowledgements:We thankHanishi K., HiramatsuM., Yamashita I.,
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